当前位置: X-MOL 学术Pediatric Ann. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19 and Gastrointestinal and Hepatobiliary Diseases.
Pediatric Annals ( IF 1.1 ) Pub Date : 2021-08-01 , DOI: 10.3928/19382359-20210721-02
Anita Rao , Mora Puertolas , Joseph Runde

Since its initial onset in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread quickly across the globe, resulting in the potentially life-threatening respiratory coronavirus disease 2019 (COVID-19). Although less commonly reported, COVID-19 has also been associated with gastrointestinal and hepatic manifestations, which may occur more frequently in children. This has also led to concern about the susceptibility of children to the SARS-CoV-2 virus who have underlying chronic digestive disease and may be treated with immune suppression. As such, recommendations and expert consensus regarding the management of chronic gastrointestinal and hepatobiliary disease have been of great interest during the pandemic and international database reporting has informed our understanding. The impact of COVID-19 on the gastrointestinal tract and its influence on the management of pediatric digestive disease is reviewed in this article. [Pediatr Ann. 2021;50(8):e315-e319.].

中文翻译:

COVID-19 和胃肠道和肝胆疾病。

自 2019 年首次发病以来,严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 在全球迅速传播,导致 2019 年可能危及生命的呼吸道冠状病毒病 (COVID-19)。尽管报道较少,但 COVID-19 也与胃肠道和肝脏表现有关,这在儿童中可能更常见。这也引起了人们对患有潜在慢性消化系统疾病并可能接受免疫抑制治疗的儿童对 SARS-CoV-2 病毒的易感性的担忧。因此,在大流行期间,关于慢性胃肠道和肝胆疾病管理的建议和专家共识引起了人们的极大兴趣,国际数据库报告也为我们提供了理解。本文综述了 COVID-19 对胃肠道的影响及其对小儿消化系统疾病管理的影响。[小儿安。2021;50(8):e315-e319.]。
更新日期:2021-08-01
down
wechat
bug